Serology testing for SARS-CoV-2 is currently experiencing an increased demand. Serology testing can give greater detail into the prevalence of a disease in a population by identifying individuals who have developed antibodies to the virus. This report covers the technologies of select companies that have either applied for regulatory approval or have received approval in US, Europe, South Korea and China.
Thank you for your interest in this report. This report will be available to purchase for a price of US $299.
Can you get similar information from a quick search in Google?
Surely not. Extracting information presented in this report would take some skill and more importantly inordinate amount of time.
SciTech Patent Art’s searchers are experts at
- Searching for technical information buried in public sources such as annual reports, YouTube videos, technical publications, patents, websites, etc.
- Use of Deep Web and AI/ML tools to extract information that is not reasily retrievable through Google
- Rapidly screening and summarizing technical information and
- Presenting summarized information in a simple, readily digest-able format.
Who is this information useful for?
It is useful for professionals who need a quick overview of Cepheid, Inc.’s technology for research to improve detection technology or competitive monitoring or developing an investment thesis.
Professionals who might find this report most useful are:
- R&D professionals
- IP staff
- Business/Marketing professionals
- Investors
Table of Contents
*Click on any tab below to view sample slides
Thank you for your interest in this report. This report will be available to purchase for a price of US $299.